Back to Agenda
KEYNOTE ADDRESS 2
Session Chair(s)
Kyoko Minamoto
Medical Technologist
National Cancer Center, Japan
Motohide Nishi, MBA
Japan Site Leader & VP Professional Services
Medidata Solutions K.K., Japan
This session will present the status of Japan Agency for Medical Research and Development (AMED) initiatives and how they will change new drug development trends in the future. Specific topics will include AMED’s vision and role, trends in and examples of information and communications technology foundation projects, and data survey details (such as examination of registry, medical information, etc.).
Speaker(s)
AMED’s Activities to Develop Infrastructure for Promoting Medical Research and Development
Noriatsu Kono, MPharm
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Organizational management
Engagement of ICT Infrastructure Development Group of AMED
Tetsuo Sakamaki, MD, PhD
Japan Agency for Medical Research and Development (AMED), Japan
Program Supervisor
Have an account?